Van Andel Institute researchers discovered that cancer risk may be determined before birth due to distinct epigenetic states ...

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside ...

A study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence ...

Cases of prostate cancer are on the rise in California, according to new research. A study by UC San Francisco (UCSF) included nearly 388,000 men who had prostate cancer between 2004 and 2021.

As an example, BRCA mutations correlate with sensitivity to platinum chemotherapy and PARP inhibitors. Preclinical studies of several tumor types, including prostate cancer, have shown that local ...

Results of a study led by the Vall d'Hebron Institute of Oncology (VHIO) support the feasibility of using RAD51 testing to ...

Announcing a new publication for Acta Materia Medica journal. Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men.

Danelle Scalia never imagined that she would be fighting for her life against ovarian cancer at the age of just 41.But her ...

The findings could lead to genetic tests that predict the likelihood of disease recurrence in breast cancer patients and ...